These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 33509796)

  • 1. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 3. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado
    Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
    Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
    Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F
    Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
    Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
    Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
    Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
    Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
    [No Abstract]   [Full Text] [Related]  

  • 8. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
    Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM
    Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis
    Schulze-Koops H; Krueger K; Specker C
    Ann Rheum Dis; 2021 Apr; 80(4):e61. PubMed ID: 32475833
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
    Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
    Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco.
    Wafa A; Hicham H; Hajar K; Mouna M; Zoubida MT; Mohamed A
    Pan Afr Med J; 2020; 37():240. PubMed ID: 33552358
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.
    Aydın F; Kurt T; Sezer M; Tekgöz N; Ekici Tekin Z; Kanık Yüksek S; Çelikel Acar B
    Int J Clin Pract; 2021 Jul; 75(7):e14030. PubMed ID: 34233400
    [No Abstract]   [Full Text] [Related]  

  • 13. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease.
    Robinson PC; Kim AHJ
    Best Pract Res Clin Rheumatol; 2021 Mar; 35(1):101664. PubMed ID: 33610466
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
    Fragoulis GE; Evangelatos G; Arida A; Bournia VK; Fragiadaki K; Karamanakos A; Kravvariti E; Laskari K; Panopoulos S; Pappa M; Tektonidou MG; Sfikakis PP
    Ann Rheum Dis; 2021 Apr; 80(4):e60. PubMed ID: 32475830
    [No Abstract]   [Full Text] [Related]  

  • 15. The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease.
    Koppert TY; Jacobs JWG; Geenen R
    Rheumatology (Oxford); 2021 Aug; 60(8):3709-3715. PubMed ID: 33313870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases.
    Palmer JL; Siddle HJ; Redmond AC; Alcacer-Pitarch B
    J Foot Ankle Res; 2021 Jan; 14(1):4. PubMed ID: 33413562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study.
    Lohse A; Bossert M; Bozgan AM; Charpentier A; Guillochon C; Bourgoin C; Balblanc JC; Conrozier T
    Clin Exp Rheumatol; 2020; 38(6):1273. PubMed ID: 33253100
    [No Abstract]   [Full Text] [Related]  

  • 19. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
    Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Dagna L; Tavoni A; Caso F; Ursini F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; Abignano G; De Santis M; Lubrano E; Fusaro E; Rossa AD; Spinella A; Lumetti F; De Luca G; Bellando-Randone S; Visalli E; Dal Bosco Y; Amato G; Giannini D; Bilia S; Masini F; Pellegrino G; Pigatto E; Generali E; Mariano GP; Pettiti G; Zanframundo G; Brittelli R; Aiello V; Caminiti R; Scorpiniti D; Ferrari T; Campochiaro C; Brusi V; Fredi M; Moschetti L; Cacciapaglia F; Gragnani L; Monti M; Lorini S; Paparo SR; Ragusa F; Mazzi V; Elia G; Ferrari SM; Di Cola I; Vadacca M; Lorusso S; Barsotti S; Aprile ML; Marco T; Miccoli M; Bosello S; Matucci-Cerinic M; D'Angelo S; Doria A; Franceschini F; Meliconi R; Iannone F; Giacomelli R; Zignego AL; Fallahi P; Antonelli A
    Curr Pharm Des; 2021; 27(41):4245-4252. PubMed ID: 34477509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.